
Strategy for the control of drug-induced liver injury due to investigational treatments/drugs for COVID-19
Author(s) -
Ken Sato,
Yuichi Yamazaki,
Toshio Uraoka
Publication year - 2021
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v27.i48.8370
Subject(s) - medicine , drug , liver injury , covid-19 , investigational drugs , pharmacology , intensive care medicine , disease , clinical trial , virology , infectious disease (medical specialty) , outbreak